High doses of Antisecretory Factor stop diarrhea fast without recurrence for six weeks post treatment

Shakila Zaman1, Khalida Aamir2, Lars Å Hanson3

  • 1Department of Public Health, University of Health Sciences, Lahore, Pakistan.

Insights

High doses of Salovum® effectively treated diarrhea in young children, with no recurrence observed over a 6-week follow-up period. This demonstrates Salovum

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Diarrheal illnesses are a significant cause of morbidity and mortality in young children in developing nations.
  • Antisecretory Factor (Salovum®) was evaluated for its efficacy in treating pediatric diarrhea.

Purpose of the Study:

  • To assess the effectiveness of two high-dose regimens of Salovum® in treating acute diarrhea in children aged 6-24 months.
  • To monitor for diarrhea recurrence for six weeks post-treatment.

Main Methods:

  • Forty children with acute diarrhea were randomly assigned to receive either 2 or 4 sachets of Salovum® mixed with Oral Rehydration Salts.
  • Stool frequency and consistency were monitored for 4 hours post-administration.
  • A 6-week follow-up was conducted daily via telephone or home visits.

Main Results:

  • The group receiving 4 sachets of Salovum® demonstrated significantly improved fecal consistency (80%) compared to the 2-sachet group (50%) within 30 minutes (p=0.004).
  • No significant difference was observed in the reduction of diarrheal stools over 4 hours between the groups (p=0.234).
  • No children experienced diarrhea recurrence during the 6-week follow-up period.

Conclusions:

  • High, perorally administered doses of Salovum® rapidly and safely resolve diarrhea in children.
  • Treatment with Salovum® resulted in a sustained diarrhea-free period of at least 6 weeks.
Abstract

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
736
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
320
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.6K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Fast Fourier Transform01:10

Fast Fourier Transform

The Fast Fourier Transform (FFT) is a computational algorithm designed to compute the Discrete Fourier Transform (DFT) efficiently. By breaking down the calculations into smaller, manageable sections, the FFT significantly reduces the computational complexity involved. Direct computation of an N-point DFT requires N2 complex multiplications, whereas the FFT algorithm needs only (N/2)log⁡2N multiplications, offering a much faster performance.
The computational efficiency of the FFT becomes...
972